Skip to main content

COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA Requirements [PODCAST]

COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA Requirements [PODCAST]
by: Kenneth M. Kennedy of K&L Gates  -  K&L Gates Triage
Thursday, November 12, 2020

In this week’s episode, Kenneth Kennedy discusses FDA’s ongoing focus on the issuance of warning letters to firms marketing fraudulent COVID-19 products, and to manufacturers who have failed to meet certain requirements under applicable FDA Emergency Use Authorizations (EUAs), as well as what manufacturers and health care providers alike can learn from this trend.

Copyright 2024 K & L Gates